The success and challenges of introducing PARP inhibitors into the therapy of ovarian cancer- a clinician’s perspective
Prof. Jonathan A Ledermann BSc MD FRCP FMedSci, Hybrid lecture
17 June 2021, 14:00
Zoom
The success and challenges of introducing PARP inhibitors into the therapy of ovarian cancer - a clinician’s perspective.
Speaker: Prof. Jonathan A Ledermann BSc MD FRCP FMedSci
Clinical Director
UCL Cancer Institute
University College London, UK
Hybrid lecture
Candiotty Auditorium, Weizmann Institute Of Science
To join the meeting click here:
https://weizmann.zoom.us/j/5065402023?pwd=a3Z6KzRCU0xJaUFoM2Y5emZwZm1oZz09#success
